Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Alphawave extends Qualcomm PUSU deadline for second time

(Sharecast News) - UK-listed tech group Alphawave has confirmed that it is still engaged in talks with semiconductor giant Qualcomm about a possible takeover as the takeover panel extended the 'put up or shut up' deadline by two weeks. Qualcomm first announced on 1 April that it was considering making an offer for Alphawave, which designs high-speed connectivity solutions for data centers, autonomous vehicles and 5G wireless infrastructure.

After extending the takeover deadline - by which Qualcomm is required either to announce a firm intention to make an offer or walk away - from 29 April to 12 May, Alphawave said the cutoff time has again been moved to 27 May.

"This deadline can be extended by the board of Alphawave with the consent of the Takeover Panel, in accordance with Rule 2.6(c) of the Code," Alphawave said on Monday.

"There can be no certainty that a firm offer will be made, nor as to the terms on which it will be made. A further announcement will be made as and when appropriate."

Alphawave shares have risen 41% since the start of April, settling at 131.93p on Friday.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.